AAAAAA

   
Results: 1-24 |
Results: 24
FAHCT accreditation: common deficiencies during on-site inspections
Authors: Warkentin, PI Nick, L Shpall, EJ
Citation: Pi. Warkentin et al., FAHCT accreditation: common deficiencies during on-site inspections, CYTOTHERAPY, 2(3), 2000, pp. 213-220
Status of high-dose chemotherapy for breast cancer: A review
Authors: Nieto, Y Champlin, RE Wingard, JR Vredenburgh, JJ Elias, AD Richardson, PR Glaspy, J Jones, RB Stiff, PJ Bearman, SI Cagnoni, PJ McSweeney, PA LeMaistre, CF Pecora, AL Shpall, EJ
Citation: Y. Nieto et al., Status of high-dose chemotherapy for breast cancer: A review, BIOL BLOOD, 6(5), 2000, pp. 476-495
Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU(STAMP-I) for breast cancer
Authors: Nieto, Y Cagnoni, PJ Bearman, SI Shpall, EJ Matthes, S Jones, RB
Citation: Y. Nieto et al., Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU(STAMP-I) for breast cancer, BIOL BLOOD, 6(2A), 2000, pp. 198-203
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation
Authors: Nieto, Y Cagnoni, PJ Nawaz, S Shpall, EJ Yerushalmi, R Cook, B Russell, P McDermit, J Murphy, J Bearman, SI Jones, RB
Citation: Y. Nieto et al., Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation, J CL ONCOL, 18(10), 2000, pp. 2070-2080
Increased expansion and differentiation of cord blood products using a two-step expansion culture
Authors: McNiece, I Kubegov, D Kerzic, P Shpall, EJ Gross, S
Citation: I. Mcniece et al., Increased expansion and differentiation of cord blood products using a two-step expansion culture, EXP HEMATOL, 28(10), 2000, pp. 1181-1186
Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia
Authors: Howrey, RP Martin, PL Driscoll, T Szabolcs, P Kelly, T Shpall, EJ Bearman, SI Slat-Vasquez, V Rubinstein, P Stevens, CE Kurtzberg, J
Citation: Rp. Howrey et al., Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia, BONE MAR TR, 26(11), 2000, pp. 1251-1254
Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation
Authors: Nieto, Y Russ, P Everson, G Bearman, SI Cagnoni, PJ Jones, RB Shpall, EJ
Citation: Y. Nieto et al., Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation, BONE MAR TR, 26(1), 2000, pp. 109-111
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer
Authors: McNiece, I Jones, R Bearman, SI Cagnoni, P Nieto, Y Franklin, W Ryder, J Steele, A Stoitz, J Russell, P McDermitt, J Hogan, C Murphy, J Shpall, EJ
Citation: I. Mcniece et al., Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer, BLOOD, 96(9), 2000, pp. 3001-3007
Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer
Authors: McNiece, I Jones, R Cagnoni, P Bearman, S Nieto, Y Shpall, EJ
Citation: I. Mcniece et al., Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer, HEM CELL TH, 41(2), 1999, pp. 82-86
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease
Authors: Nieto, Y Cagnoni, PJ Shpall, EJ Matthes, S Baron, A Jones, RB Bearman, SI
Citation: Y. Nieto et al., Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease, CLIN CANC R, 5(7), 1999, pp. 1731-1737
Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea
Authors: Nieto, Y Xu, XH Cagnoni, PJ Matthes, S Shpall, EJ Bearman, SI Murphy, J Jones, RB
Citation: Y. Nieto et al., Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea, CLIN CANC R, 5(4), 1999, pp. 747-751
Acute encephalopathy: A new toxicity associated with high-dose paclitaxel
Authors: Nieto, Y Cagnoni, PJ Bearman, SI Shpall, EJ Matthes, S DeBoom, T Baron, A Jones, RB
Citation: Y. Nieto et al., Acute encephalopathy: A new toxicity associated with high-dose paclitaxel, CLIN CANC R, 5(3), 1999, pp. 501-506
A predictive model for relapse in high-risk primary breast cancer patientstreated with high-dose chemotherapy and autologous stem-cell transplant
Authors: Nieto, Y Cagnoni, PJ Shpall, EJ Xu, XS Murphy, J Vredenburgh, J Chao, NJ Bearman, SI Jones, RB
Citation: Y. Nieto et al., A predictive model for relapse in high-risk primary breast cancer patientstreated with high-dose chemotherapy and autologous stem-cell transplant, CLIN CANC R, 5(11), 1999, pp. 3425-3431
Peripheral blood stem cell transplantation in breast cancer
Authors: Shpall, EJ Jones, RB Bearman, SI Cagnoni, PJ Nieto, Y McNiece, IK
Citation: Ej. Shpall et al., Peripheral blood stem cell transplantation in breast cancer, BAIL CLIN H, 12(1-2), 1999, pp. 219-232
Autologous stem-cell transplantation for solid tumors in adults
Authors: Nieto, Y Shpall, EJ
Citation: Y. Nieto et Ej. Shpall, Autologous stem-cell transplantation for solid tumors in adults, HEMAT ONCOL, 13(5), 1999, pp. 939
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support
Authors: Rizzieri, DA Vredenburgh, JJ Jones, R Ross, M Shpall, EJ Hussein, A Broadwater, G Berry, D Petros, WP Gilbert, C Affronti, ML Coniglio, D Rubin, P Elkordy, M Long, GD Chao, NJ Peters, WP
Citation: Da. Rizzieri et al., Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support, J CL ONCOL, 17(10), 1999, pp. 3064-3074
Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support
Authors: Johnson, DW Cagnoni, PJ Schossau, TM Stemmer, SM Grayeb, DEM Baron, AE Shpall, EJ Bearman, SI McDermitt, J Jones, RB
Citation: Dw. Johnson et al., Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support, BONE MAR TR, 24(7), 1999, pp. 785-792
High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy
Authors: Bearman, SI Vredenburh, JJ Cagnoni, PJ Shpall, EJ Nieto, Y Ross, M Peters, WP Jones, RB
Citation: Si. Bearman et al., High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy, BONE MAR TR, 24(5), 1999, pp. 491-495
Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics
Authors: Cagnoni, PJ Matthes, S Day, TC Bearman, SI Shpall, EJ Jones, RB
Citation: Pj. Cagnoni et al., Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics, BONE MAR TR, 24(1), 1999, pp. 1-4
The utilization of cytokines in stem cell mobilization strategies
Authors: Shpall, EJ
Citation: Ej. Shpall, The utilization of cytokines in stem cell mobilization strategies, BONE MAR TR, 23, 1999, pp. S13-S19
Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant
Authors: Nieto, Y Ross, M Gianani, R Shpall, EJ Cagnoni, PJ Bearman, SI Jones, RB
Citation: Y. Nieto et al., Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant, BONE MAR TR, 23(12), 1999, pp. 1323-1324
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone
Authors: Franklin, WA Glaspy, J Pflaumer, SM Jones, RB Hami, L Martinez, C Murphy, JR Shpall, EJ
Citation: Wa. Franklin et al., Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone, BLOOD, 94(1), 1999, pp. 340-347
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients
Authors: Shpall, EJ Wheeler, CA Turner, SA Yanovich, S Brown, RA Pecora, AL Shea, TC Mangan, KF Williams, SF LeMaistre, CF Long, GD Jones, R Davis, MW Murphy-Filkins, R Parker, WRL Glaspy, JA
Citation: Ej. Shpall et al., A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients, BLOOD, 93(8), 1999, pp. 2491-2501
The use of cytokines to enhance collection of stem cells for marrow and blood transplantation
Authors: Roman-Unfer, S Shpall, EJ
Citation: S. Roman-unfer et Ej. Shpall, The use of cytokines to enhance collection of stem cells for marrow and blood transplantation, CLINICAL APPLICATIONS OF CYTOKINES AND GROWTH FACTORS, 1999, pp. 369-380
Risultati: 1-24 |